Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluating Patient Information Prescriptions
This study is currently recruiting participants.
Verified by Johns Hopkins University, May 2005
Sponsored by: Johns Hopkins University
Information provided by: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00355381
  Purpose

Research shows that patient satisfaction with medical care correlates strongly with how satisfied they are with the ease of getting information from their providers regarding their medical condition. Although the Internet is a wonderful source of information for patients, research has shown that, unmediated, it comprises a potential quagmire of information poorly matched to users needs. Providers typically do not have enough time to fulfill all of their patients' information needs. One strategy to meeting the patient's information needs is to introduce librarians trained and experienced in consumer health information services into the relationship between the patient and the provider. One recently described tactic is for providers to provide information the way they of provide treatment-through an information prescription (IRx) filled by a librarian. The librarian fills the prescription by offering information services tailored to the needs of individual patients. At Johns Hopkins, we have piloted such a tactic, and in this project, extend and evaluate it. The research hypothesis is that provision of an IRx will improve patient satisfaction, provider knowledge and attitudes regarding patient information needs, and the efficiencies of care.


Condition Intervention Phase
Breast Neoplasms
Premature Birth
Behavioral: Information Services (IRx)
Phase II

Genetics Home Reference related topics: breast cancer
MedlinePlus related topics: Breast Cancer Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: Evaluating Patient Information Prescriptions in Different Service Environments

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Patient Satisfaction

Secondary Outcome Measures:
  • provider perceptions and behavior will be assessed;costs entailed and resources utilized will be assessed;how the intervention (information services) generalizes across service environments

Estimated Enrollment: 600
Study Start Date: September 2004
Estimated Study Completion Date: September 2007
Detailed Description:

The goal of this research is to evaluate IRx, to provide enough data so care organizations can decide whether to implement this in their own environment.

To that end, our specific aims are:

  1. To evaluate the impact of IRx on patients. We are performing a randomized clinical trial, comparing IRx with standard provision of information. The primary outcome is patient satisfaction.
  2. To evaluate the impact of IRx on providers. As part of the trial, provider perceptions and behavior will be assessed.
  3. To evaluate the impact of IRx on the health-care system. As part of the trial, costs entailed and resources utilized will be assessed.
  4. To evaluate how IRx generalizes across service environments. The trial will be performed in two environments: adult breast cancer and neonatal intensive care.

At the heart of this proposal are the randomized clinical trials. In each, patients in both intervention and control groups will receive standard clinical care in their clinic visits. Patients randomized to the intervention group will receive information services from a specially trained librarian; patients in the control groups will receive routine, current information provision. For Aim 1, immediately after their clinic visits and four weeks later, all participants will report their satisfaction on a survey that include measures of patient-provider communication. For Aim 2, participating providers are surveyed for their perceptions of information needs being met and about patient-provider interaction. For Aim 3, costs of care and costs of providing the IRx environment will be tabulated.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Breast Cancer: any new patient seen in Johns Hopkins medical oncolgy for Breast Cancer
  • Neonatal Intensive care:Biological mothers (or consenting guardians) of premature infants born and admitted or transferred in to Johns Hopkins Hospital or Bayview Medical Center neonatal intensive care units.

Exclusion Criteria:

  • Breast Cancer: None
  • Neonatal Intensive Care: Parents with infants whose SNAP mortality >= 80%(J Pediatr. 2001 Jan;138(1):92-100)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00355381

Contacts
Contact: Nancy K Roderer, MLS 410 614 6900 nroderer@jhmi.edu
Contact: Kathleen B Oliver, MLS, MPH 410 614 6801 koliver@jhmi.edu

Locations
United States, Maryland
Johns Hopkins School of Medicine Recruiting
Baltimore, Maryland, United States, 21205
Principal Investigator: Nancy K Roderer, MLS            
Sub-Investigator: Kathleen B Oliver, MLS, MPH            
Sub-Investigator: Lehmann Lehmann, MD, PhD            
Sub-Investigator: Antonio Wolff, MD            
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Nancy K Oliver, MLS Johns Hopkins School of Medicine
Study Director: Kathleen B Oliver, MLS, MPH Johns Hopkins School of Medicine
  More Information

Study ID Numbers: JHU 04-09-03-01, 1 R01 LM008143
Study First Received: July 19, 2006
Last Updated: September 7, 2006
ClinicalTrials.gov Identifier: NCT00355381  
Health Authority: United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
Information Services
Randomized Controlled Trials
Medical Records Systems, Computerized
Internet
Librarians
Breast Neoplasms
Patient Satisfaction
Health Personnel
Costs and Cost Analysis
Premature Birth

Study placed in the following topic categories:
Pregnancy Complications
Skin Diseases
Obstetric Labor, Premature
Obstetric Labor Complications
Breast Neoplasms
Breast Diseases
Premature Birth

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 14, 2009